Aspire Biopharma

(NASDAQ) ASBP

Current Price$5.40

Market Cap$7.84M

Since IPO (2022)-100%

5 YearN/A

1 Year-99%

1 Month+1%

Aspire Biopharma Financials at a Glance

Market Cap

$7.84M

Revenue (TTM)

$34.56K

Net Income (TTM)

-$11.76M

EPS (TTM)

-$153.56

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

0.65 (Low)

Dividend

$0.00

Beta (Volatility)

0.65 (Low)

Price

$5.40

Volume

84,374.405

Open

$5.95

Price

$5.40

Volume

84,374.405

Open

$5.95

Previous Close

$6.05

Daily Range

$5.32 - $6.00

52-Week Range

$3.31 - $1,050.36

Estimated Earnings Date

May 13, 2026

Dividend

$0.00

Beta (Volatility)

0.65 (Low)

Price

$5.40

Volume

84,374.405

Open

$5.95

Previous Close

$6.05

Daily Range

$5.32 - $6.00

52-Week Range

$3.31 - $1,050.36

Estimated Earnings Date

May 13, 2026

ASBP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aspire Biopharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Kraig T. Higginson

Website

www.aspirebiolabs.com

Headquarters

Estero, FL 33928, US

ASBP Financials

Key Financial Metrics (TTM)

Gross Margin

16%

Operating Margin

-157%

Net Income Margin

-340%

Return on Equity

-490%

Return on Capital

-1%

Return on Assets

-2%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.84M

Shares Outstanding

1.30M

Volume

84.37K

Avg. Volume

553.43K

Financials (TTM)

Gross Profit

-$116.00

Operating Income

-$19.35M

EBITDA

-$19.35M

Operating Cash Flow

-$4.92M

Capital Expenditure

$0.00

Free Cash Flow

-$4.92M

Cash & ST Invst.

$1.00M

Total Debt

$1.38M

Aspire Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$28.35K

N/A

Gross Profit

$5.75K

N/A

Gross Margin

20.28%

N/A

Market Cap

$7.84M

N/A

Market Cap/Employee

$3.92M

N/A

Employees

N/A

Net Income

-$3.22M

+79.8%

EBITDA

-$1.65M

+89.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$5.36M

+1571.9%

Accounts Receivable

$0.00

N/A

Inventory

$369.97K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$499.21K

-70.8%

Return on Assets

-1.65%

N/A

Return on Invested Capital

-1.37%

N/A

Free Cash Flow

-$3.04M

-73.5%

Operating Cash Flow

-$3.04M

-73.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CAUDCollective Audience, Inc.

CAUDCollective Audience, Inc.$0.01-0.99%

FIACFocus Impact Acquisition Corp.

FIACFocus Impact Acquisition Corp.$8.88-10.48%

GAMCGolden Arrow Merger Corp.

GAMCGolden Arrow Merger Corp.$9.00-22.41%

BOCNBlue Ocean Acquisition Corp.

BOCNBlue Ocean Acquisition Corp.$10.72N/A

CSLMConsilium Acquisition Corp I, Ltd.

CSLMConsilium Acquisition Corp I, Ltd.$11.69+0.00%

CHAACatcha Investment Corp

CHAACatcha Investment Corp$8.90+7.23%

WELIntegrated Wellness Acquisition Corp

WELIntegrated Wellness Acquisition Corp$11.86-0.59%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.33-0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.21-0.13%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.04-0.15%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.68+0.13%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.15-0.05%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$708.79-0.04%

Questions About ASBP

What is the current price of Aspire Biopharma?

Aspire Biopharma is trading at $5.33 per share.

What is the 52-week range for Aspire Biopharma?

Over the past 52 weeks, Aspire Biopharma has traded between $3.31 and $1,050.36.

How much debt does Aspire Biopharma have?

As of the most recent reporting period, Aspire Biopharma reported total debt of $1.50M.

How much cash does Aspire Biopharma have on hand?

Aspire Biopharma reported $5.86M in cash and cash equivalents in its most recent financial results.

What is Aspire Biopharma’s dividend yield?

Aspire Biopharma does not currently have a dividend yield.

Aspire Biopharma

Aspire Biopharma Financials at a Glance

ASBP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aspire Biopharma

ASBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aspire Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ASBP

What is the current price of Aspire Biopharma?

What is the 52-week range for Aspire Biopharma?

How much debt does Aspire Biopharma have?

How much cash does Aspire Biopharma have on hand?

What is Aspire Biopharma’s dividend yield?

Premium Investing Services